Dm. Benbrook et al., BIOLOGICAL ASSAY FOR ACTIVITY AND MOLECULAR MECHANISM OF RETINOIDS INCERVICAL TUMOR-CELLS, Gynecologic oncology, 66(1), 1997, pp. 114-121
The composition and response of the retinoid signaling pathway in a hu
man cell line (CC-1), representative of a low grade cervical carcinoma
, were evaluated. Reverse-transcriptase polymerase chain reaction (RT-
PCR) analysis demonstrated expression of cytoplasmic retinol binding p
rotein, CRBPI, cytoplasmic retinoic acid binding protein, CRABPII, and
nuclear retinoic acid receptors, RAR alpha, RAR gamma, RXR alpha, and
RXR beta, but not CRABPI or RAR beta. This pattern is similar to that
of the ectocervix. Activation of endogenous nuclear receptors was eva
luated in a reporter subline of CC-1, called CC-B, containing a report
er gene controlled by a retinoic acid responsive element (RARE) and th
ymidine kinase promoter. Retinoid treatment of CC-B resulted in dose-d
ependent increases in reporter gene expression. Retinoids inhibited gr
owth at concentrations greater than 100 nM. 9-cis retinoic acid (1 nM)
significantly stimulated growth. Immunohistochemical analysis of CC-B
organotypic cultures demonstrated a high level of epidermal growth fa
ctor receptor (EGF-R) expression that was decreased by retinoids. The
degree of RARE transactivation induced by retinoids significantly corr
elated with the degree of inhibition of growth (R = (-)0.96) and EGF-R
expression (R = (-)0.92), The dose-dependent and retinoid-specific re
sponses of CC-1 at the molecular and biological levels demonstrate the
utility of this reporter cell line for evaluation of retinoid activit
ies. (C) 1997 Academic Press.